189 related articles for article (PubMed ID: 38495100)
21. Antibody-Drug Conjugates with Pyrrole-Based KSP Inhibitors as the Payload Class.
Lerchen HG; Wittrock S; Stelte-Ludwig B; Sommer A; Berndt S; Griebenow N; Rebstock AS; Johannes S; Cancho-Grande Y; Mahlert C; Greven S; Terjung C
Angew Chem Int Ed Engl; 2018 Nov; 57(46):15243-15247. PubMed ID: 30180286
[TBL] [Abstract][Full Text] [Related]
22. Enzyme-Agnostic Lysosomal Screen Identifies New Legumain-Cleavable ADC Linkers.
Miller JT; Vitro CN; Fang S; Benjamin SR; Tumey LN
Bioconjug Chem; 2021 Apr; 32(4):842-858. PubMed ID: 33788548
[TBL] [Abstract][Full Text] [Related]
23. Fibroblast Activation Protein Triggers Release of Drug Payload from Non-internalizing Small Molecule Drug Conjugates in Solid Tumors.
Zana A; Galbiati A; Gilardoni E; Bocci M; Millul J; Sturm T; Stucchi R; Elsayed A; Nadal L; Cirillo M; Roll W; Stegger L; Asmus I; Backhaus P; Schäfers M; Neri D; Cazzamalli S
Clin Cancer Res; 2022 Dec; 28(24):5440-5454. PubMed ID: 36215129
[TBL] [Abstract][Full Text] [Related]
24. Advancements in folate receptor targeting for anti-cancer therapy: A small molecule-drug conjugate approach.
Rana A; Bhatnagar S
Bioorg Chem; 2021 Jul; 112():104946. PubMed ID: 33989916
[TBL] [Abstract][Full Text] [Related]
25. Hydrophilic Auristatin Glycoside Payload Enables Improved Antibody-Drug Conjugate Efficacy and Biocompatibility.
Satomaa T; Pynnönen H; Vilkman A; Kotiranta T; Pitkänen V; Heiskanen A; Herpers B; Price LS; Helin J; Saarinen J
Antibodies (Basel); 2018 Mar; 7(2):. PubMed ID: 31544867
[TBL] [Abstract][Full Text] [Related]
26. Lysosomal P-gp-MDR1 Confers Drug Resistance of Brentuximab Vedotin and Its Cytotoxic Payload Monomethyl Auristatin E in Tumor Cells.
Liu-Kreyche P; Shen H; Marino AM; Iyer RA; Humphreys WG; Lai Y
Front Pharmacol; 2019; 10():749. PubMed ID: 31379564
[TBL] [Abstract][Full Text] [Related]
27. Linker stability influences the anti-tumor activity of acetazolamide-drug conjugates for the therapy of renal cell carcinoma.
Cazzamalli S; Corso AD; Neri D
J Control Release; 2017 Jan; 246():39-45. PubMed ID: 27890855
[TBL] [Abstract][Full Text] [Related]
28. RGD Peptidomimetic MMAE-Conjugate Addressing Integrin αVβ3-Expressing Cells with High Targeting Index.
Paulus J; Nachtigall B; Meyer P; Sewald N
Chemistry; 2023 Feb; 29(12):e202203476. PubMed ID: 36454662
[TBL] [Abstract][Full Text] [Related]
29. Novel formats of antibody conjugates: recent advances in payload diversity, conjugation, and linker chemistry.
Fujii T; Matsuda Y
Expert Opin Biol Ther; 2023; 23(11):1053-1065. PubMed ID: 37953519
[TBL] [Abstract][Full Text] [Related]
30. Antibody-drug conjugates: recent advances in conjugation and linker chemistries.
Tsuchikama K; An Z
Protein Cell; 2018 Jan; 9(1):33-46. PubMed ID: 27743348
[TBL] [Abstract][Full Text] [Related]
31. Enzymatic conjugation using branched linkers for constructing homogeneous antibody-drug conjugates with high potency.
Anami Y; Xiong W; Gui X; Deng M; Zhang CC; Zhang N; An Z; Tsuchikama K
Org Biomol Chem; 2017 Jul; 15(26):5635-5642. PubMed ID: 28649690
[TBL] [Abstract][Full Text] [Related]
32. Chemical generation of small molecule-based bispecific antibody-drug conjugates for broadening the target scope.
Yamaguchi A; Anami Y; Ha SYY; Roeder TJ; Xiong W; Lee J; Ueno NT; Zhang N; An Z; Tsuchikama K
Bioorg Med Chem; 2021 Feb; 32():116013. PubMed ID: 33482584
[TBL] [Abstract][Full Text] [Related]
33. Self-Immolative Carbamate Linkers for CD19-Budesonide Antibody-Drug Conjugates.
Marvin CC; Hobson AD; McPherson M; Dunstan TA; Vargo TR; Hayes ME; Fettis MM; Bischoff A; Wang L; Wang L; Hernandez A; Jia Y; Oh JZ; Tian Y
Bioconjug Chem; 2023 Oct; 34(10):1835-1850. PubMed ID: 37788373
[TBL] [Abstract][Full Text] [Related]
34. Prostate-Specific Membrane Antigen-Targeted Turn-on Probe for Imaging Cargo Release in Prostate Cancer Cells.
Olatunji FP; Savoy EA; Panteah M; Mesbahi N; Abbasi A; Talley CM; Lovingier CL; Caromile LA; Berkman CE
Bioconjug Chem; 2021 Nov; 32(11):2386-2396. PubMed ID: 34699177
[TBL] [Abstract][Full Text] [Related]
35. Small Molecule-Drug Conjugates Emerge as a New Promising Approach for Cancer Treatment.
Wang T; Li M; Wei R; Wang X; Lin Z; Chen J; Wu X
Mol Pharm; 2024 Mar; 21(3):1038-1055. PubMed ID: 38344996
[TBL] [Abstract][Full Text] [Related]
36. Advances in non-radioactive PSMA-targeted small molecule-drug conjugates in the treatment of prostate cancer.
Chen M; Cai L; Xiang Y; Zhong L; Shi J
Bioorg Chem; 2023 Dec; 141():106889. PubMed ID: 37813074
[TBL] [Abstract][Full Text] [Related]
37. Modular Smart Molecules for PSMA-Targeted Chemotherapy.
Olatunji FP; Pun M; Herman JW; Romero O; Maniatopoulos M; Latoche JD; Parise RA; Guo J; Beumer JH; Anderson CJ; Berkman CE
Mol Cancer Ther; 2022 Nov; 21(11):1701-1709. PubMed ID: 35999662
[TBL] [Abstract][Full Text] [Related]
38. Sulfatase-cleavable linkers for antibody-drug conjugates.
Bargh JD; Walsh SJ; Isidro-Llobet A; Omarjee S; Carroll JS; Spring DR
Chem Sci; 2020 Jan; 11(9):2375-2380. PubMed ID: 34084399
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
